Antidiabetic actions of a non-agonist PPAR[gamma] ligand blocking Cdk5-mediated phosphorylation
PPARγ is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs including rosiglitazone and pioglitazone. These drugs are full classical agonists for this nuclear receptor, but recent data have shown that many PPARγ-based drugs have a separate biochemical activity, bloc...
Gespeichert in:
| Veröffentlicht in: | Nature (London) 2011-09, Vol.477 (7365), p.477 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 7365 |
| container_start_page | 477 |
| container_title | Nature (London) |
| container_volume | 477 |
| creator | Choi, Jang Hyun Banks, Alexander S Kamenecka, Theodore M Busby, Scott A Chalmers, Michael J Kumar, Naresh Kuruvilla, Dana S Shin, Youseung He, Yuanjun Bruning, John B Marciano, David P Cameron, Michael D Laznik, Dina Jurczak, Michael J Schürer, Stephan C Vidovic, Dusica Shulman, Gerald I Spiegelman, Bruce M Griffin, Patrick R |
| description | PPARγ is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs including rosiglitazone and pioglitazone. These drugs are full classical agonists for this nuclear receptor, but recent data have shown that many PPARγ-based drugs have a separate biochemical activity, blocking the obesity-linked phosphorylation of PPARγ by Cdk5 (ref. 2). Here we describe novel synthetic compounds that have a unique mode of binding to PPARγ, completely lack classical transcriptional agonism and block the Cdk5-mediated phosphorylation in cultured adipocytes and in insulin-resistant mice. Moreover, one such compound, SR1664, has potent antidiabetic activity while not causing the fluid retention and weight gain that are serious side effects of many of the PPARγ drugs. Unlike TZDs, SR1664 also does not interfere with bone formation in culture. These data illustrate that new classes of antidiabetes drugs can be developed by specifically targeting the Cdk5-mediated phosphorylation of PPARγ. [PUBLICATION ABSTRACT] |
| doi_str_mv | 10.1038/naturel0383 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_896867471</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2480848411</sourcerecordid><originalsourceid>FETCH-proquest_journals_8968674713</originalsourceid><addsrcrecordid>eNqNjM1qAjEUhYO04PRn5Qtc3McmzpjEpYjFpZTuigzXmTiNZm50kln49h3BB-jicA58h4-xiRQzKXLzQZj6zvph5iOWyUIrXiijn1gmxNxwYXI1Zi8xnoQQC6mLjJUrSq52eLDJVYBVcoEihCMgUCCOTSAXE-x2q6-fBtsW9-Bdg1TDwYfq7KiBdX1e8NYOkmRruPyGOKS7eby73tjzEX20749-ZdPPzfd6yy9duPY2pvIU-o4GVJqlMkoXWub_Ov0BDThK3g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>896867471</pqid></control><display><type>article</type><title>Antidiabetic actions of a non-agonist PPAR[gamma] ligand blocking Cdk5-mediated phosphorylation</title><source>Springer Nature - Complete Springer Journals</source><source>Nature Journals Online</source><creator>Choi, Jang Hyun ; Banks, Alexander S ; Kamenecka, Theodore M ; Busby, Scott A ; Chalmers, Michael J ; Kumar, Naresh ; Kuruvilla, Dana S ; Shin, Youseung ; He, Yuanjun ; Bruning, John B ; Marciano, David P ; Cameron, Michael D ; Laznik, Dina ; Jurczak, Michael J ; Schürer, Stephan C ; Vidovic, Dusica ; Shulman, Gerald I ; Spiegelman, Bruce M ; Griffin, Patrick R</creator><creatorcontrib>Choi, Jang Hyun ; Banks, Alexander S ; Kamenecka, Theodore M ; Busby, Scott A ; Chalmers, Michael J ; Kumar, Naresh ; Kuruvilla, Dana S ; Shin, Youseung ; He, Yuanjun ; Bruning, John B ; Marciano, David P ; Cameron, Michael D ; Laznik, Dina ; Jurczak, Michael J ; Schürer, Stephan C ; Vidovic, Dusica ; Shulman, Gerald I ; Spiegelman, Bruce M ; Griffin, Patrick R</creatorcontrib><description>PPARγ is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs including rosiglitazone and pioglitazone. These drugs are full classical agonists for this nuclear receptor, but recent data have shown that many PPARγ-based drugs have a separate biochemical activity, blocking the obesity-linked phosphorylation of PPARγ by Cdk5 (ref. 2). Here we describe novel synthetic compounds that have a unique mode of binding to PPARγ, completely lack classical transcriptional agonism and block the Cdk5-mediated phosphorylation in cultured adipocytes and in insulin-resistant mice. Moreover, one such compound, SR1664, has potent antidiabetic activity while not causing the fluid retention and weight gain that are serious side effects of many of the PPARγ drugs. Unlike TZDs, SR1664 also does not interfere with bone formation in culture. These data illustrate that new classes of antidiabetes drugs can be developed by specifically targeting the Cdk5-mediated phosphorylation of PPARγ. [PUBLICATION ABSTRACT]</description><identifier>ISSN: 0028-0836</identifier><identifier>EISSN: 1476-4687</identifier><identifier>DOI: 10.1038/naturel0383</identifier><identifier>CODEN: NATUAS</identifier><language>eng</language><publisher>London: Nature Publishing Group</publisher><subject>Bone density ; Kinases ; Proteins ; Rodents ; Side effects</subject><ispartof>Nature (London), 2011-09, Vol.477 (7365), p.477</ispartof><rights>Copyright Nature Publishing Group Sep 22, 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Choi, Jang Hyun</creatorcontrib><creatorcontrib>Banks, Alexander S</creatorcontrib><creatorcontrib>Kamenecka, Theodore M</creatorcontrib><creatorcontrib>Busby, Scott A</creatorcontrib><creatorcontrib>Chalmers, Michael J</creatorcontrib><creatorcontrib>Kumar, Naresh</creatorcontrib><creatorcontrib>Kuruvilla, Dana S</creatorcontrib><creatorcontrib>Shin, Youseung</creatorcontrib><creatorcontrib>He, Yuanjun</creatorcontrib><creatorcontrib>Bruning, John B</creatorcontrib><creatorcontrib>Marciano, David P</creatorcontrib><creatorcontrib>Cameron, Michael D</creatorcontrib><creatorcontrib>Laznik, Dina</creatorcontrib><creatorcontrib>Jurczak, Michael J</creatorcontrib><creatorcontrib>Schürer, Stephan C</creatorcontrib><creatorcontrib>Vidovic, Dusica</creatorcontrib><creatorcontrib>Shulman, Gerald I</creatorcontrib><creatorcontrib>Spiegelman, Bruce M</creatorcontrib><creatorcontrib>Griffin, Patrick R</creatorcontrib><title>Antidiabetic actions of a non-agonist PPAR[gamma] ligand blocking Cdk5-mediated phosphorylation</title><title>Nature (London)</title><description>PPARγ is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs including rosiglitazone and pioglitazone. These drugs are full classical agonists for this nuclear receptor, but recent data have shown that many PPARγ-based drugs have a separate biochemical activity, blocking the obesity-linked phosphorylation of PPARγ by Cdk5 (ref. 2). Here we describe novel synthetic compounds that have a unique mode of binding to PPARγ, completely lack classical transcriptional agonism and block the Cdk5-mediated phosphorylation in cultured adipocytes and in insulin-resistant mice. Moreover, one such compound, SR1664, has potent antidiabetic activity while not causing the fluid retention and weight gain that are serious side effects of many of the PPARγ drugs. Unlike TZDs, SR1664 also does not interfere with bone formation in culture. These data illustrate that new classes of antidiabetes drugs can be developed by specifically targeting the Cdk5-mediated phosphorylation of PPARγ. [PUBLICATION ABSTRACT]</description><subject>Bone density</subject><subject>Kinases</subject><subject>Proteins</subject><subject>Rodents</subject><subject>Side effects</subject><issn>0028-0836</issn><issn>1476-4687</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNjM1qAjEUhYO04PRn5Qtc3McmzpjEpYjFpZTuigzXmTiNZm50kln49h3BB-jicA58h4-xiRQzKXLzQZj6zvph5iOWyUIrXiijn1gmxNxwYXI1Zi8xnoQQC6mLjJUrSq52eLDJVYBVcoEihCMgUCCOTSAXE-x2q6-fBtsW9-Bdg1TDwYfq7KiBdX1e8NYOkmRruPyGOKS7eby73tjzEX20749-ZdPPzfd6yy9duPY2pvIU-o4GVJqlMkoXWub_Ov0BDThK3g</recordid><startdate>20110922</startdate><enddate>20110922</enddate><creator>Choi, Jang Hyun</creator><creator>Banks, Alexander S</creator><creator>Kamenecka, Theodore M</creator><creator>Busby, Scott A</creator><creator>Chalmers, Michael J</creator><creator>Kumar, Naresh</creator><creator>Kuruvilla, Dana S</creator><creator>Shin, Youseung</creator><creator>He, Yuanjun</creator><creator>Bruning, John B</creator><creator>Marciano, David P</creator><creator>Cameron, Michael D</creator><creator>Laznik, Dina</creator><creator>Jurczak, Michael J</creator><creator>Schürer, Stephan C</creator><creator>Vidovic, Dusica</creator><creator>Shulman, Gerald I</creator><creator>Spiegelman, Bruce M</creator><creator>Griffin, Patrick R</creator><general>Nature Publishing Group</general><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7TG</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PCBAR</scope><scope>PDBOC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>R05</scope><scope>RC3</scope><scope>S0X</scope><scope>SOI</scope></search><sort><creationdate>20110922</creationdate><title>Antidiabetic actions of a non-agonist PPAR[gamma] ligand blocking Cdk5-mediated phosphorylation</title><author>Choi, Jang Hyun ; Banks, Alexander S ; Kamenecka, Theodore M ; Busby, Scott A ; Chalmers, Michael J ; Kumar, Naresh ; Kuruvilla, Dana S ; Shin, Youseung ; He, Yuanjun ; Bruning, John B ; Marciano, David P ; Cameron, Michael D ; Laznik, Dina ; Jurczak, Michael J ; Schürer, Stephan C ; Vidovic, Dusica ; Shulman, Gerald I ; Spiegelman, Bruce M ; Griffin, Patrick R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_8968674713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Bone density</topic><topic>Kinases</topic><topic>Proteins</topic><topic>Rodents</topic><topic>Side effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Choi, Jang Hyun</creatorcontrib><creatorcontrib>Banks, Alexander S</creatorcontrib><creatorcontrib>Kamenecka, Theodore M</creatorcontrib><creatorcontrib>Busby, Scott A</creatorcontrib><creatorcontrib>Chalmers, Michael J</creatorcontrib><creatorcontrib>Kumar, Naresh</creatorcontrib><creatorcontrib>Kuruvilla, Dana S</creatorcontrib><creatorcontrib>Shin, Youseung</creatorcontrib><creatorcontrib>He, Yuanjun</creatorcontrib><creatorcontrib>Bruning, John B</creatorcontrib><creatorcontrib>Marciano, David P</creatorcontrib><creatorcontrib>Cameron, Michael D</creatorcontrib><creatorcontrib>Laznik, Dina</creatorcontrib><creatorcontrib>Jurczak, Michael J</creatorcontrib><creatorcontrib>Schürer, Stephan C</creatorcontrib><creatorcontrib>Vidovic, Dusica</creatorcontrib><creatorcontrib>Shulman, Gerald I</creatorcontrib><creatorcontrib>Spiegelman, Bruce M</creatorcontrib><creatorcontrib>Griffin, Patrick R</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric & Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Earth, Atmospheric & Aquatic Science Database</collection><collection>Materials Science Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>University of Michigan</collection><collection>Genetics Abstracts</collection><collection>SIRS Editorial</collection><collection>Environment Abstracts</collection><jtitle>Nature (London)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Choi, Jang Hyun</au><au>Banks, Alexander S</au><au>Kamenecka, Theodore M</au><au>Busby, Scott A</au><au>Chalmers, Michael J</au><au>Kumar, Naresh</au><au>Kuruvilla, Dana S</au><au>Shin, Youseung</au><au>He, Yuanjun</au><au>Bruning, John B</au><au>Marciano, David P</au><au>Cameron, Michael D</au><au>Laznik, Dina</au><au>Jurczak, Michael J</au><au>Schürer, Stephan C</au><au>Vidovic, Dusica</au><au>Shulman, Gerald I</au><au>Spiegelman, Bruce M</au><au>Griffin, Patrick R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antidiabetic actions of a non-agonist PPAR[gamma] ligand blocking Cdk5-mediated phosphorylation</atitle><jtitle>Nature (London)</jtitle><date>2011-09-22</date><risdate>2011</risdate><volume>477</volume><issue>7365</issue><spage>477</spage><pages>477-</pages><issn>0028-0836</issn><eissn>1476-4687</eissn><coden>NATUAS</coden><abstract>PPARγ is the functioning receptor for the thiazolidinedione (TZD) class of antidiabetes drugs including rosiglitazone and pioglitazone. These drugs are full classical agonists for this nuclear receptor, but recent data have shown that many PPARγ-based drugs have a separate biochemical activity, blocking the obesity-linked phosphorylation of PPARγ by Cdk5 (ref. 2). Here we describe novel synthetic compounds that have a unique mode of binding to PPARγ, completely lack classical transcriptional agonism and block the Cdk5-mediated phosphorylation in cultured adipocytes and in insulin-resistant mice. Moreover, one such compound, SR1664, has potent antidiabetic activity while not causing the fluid retention and weight gain that are serious side effects of many of the PPARγ drugs. Unlike TZDs, SR1664 also does not interfere with bone formation in culture. These data illustrate that new classes of antidiabetes drugs can be developed by specifically targeting the Cdk5-mediated phosphorylation of PPARγ. [PUBLICATION ABSTRACT]</abstract><cop>London</cop><pub>Nature Publishing Group</pub><doi>10.1038/naturel0383</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-0836 |
| ispartof | Nature (London), 2011-09, Vol.477 (7365), p.477 |
| issn | 0028-0836 1476-4687 |
| language | eng |
| recordid | cdi_proquest_journals_896867471 |
| source | Springer Nature - Complete Springer Journals; Nature Journals Online |
| subjects | Bone density Kinases Proteins Rodents Side effects |
| title | Antidiabetic actions of a non-agonist PPAR[gamma] ligand blocking Cdk5-mediated phosphorylation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A55%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antidiabetic%20actions%20of%20a%20non-agonist%20PPAR%5Bgamma%5D%20ligand%20blocking%20Cdk5-mediated%20phosphorylation&rft.jtitle=Nature%20(London)&rft.au=Choi,%20Jang%20Hyun&rft.date=2011-09-22&rft.volume=477&rft.issue=7365&rft.spage=477&rft.pages=477-&rft.issn=0028-0836&rft.eissn=1476-4687&rft.coden=NATUAS&rft_id=info:doi/10.1038/naturel0383&rft_dat=%3Cproquest%3E2480848411%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=896867471&rft_id=info:pmid/&rfr_iscdi=true |